Future research on PUMA in cancer is likely to focus on understanding its regulatory mechanisms in greater detail and identifying biomarkers for predicting response to PUMA-targeted therapies. Advances in gene editing and delivery technologies may also facilitate the development of more precise and effective PUMA-based treatments. Additionally, exploring the role of PUMA in the tumor microenvironment and its interactions with other cell death pathways could provide new insights into its therapeutic potential.
